AstraZeneca PLC (LSE:AZN)
£ 106.12 0.8 (0.76%) Market Cap: 164.52 Bil Enterprise Value: 185.50 Bil PE Ratio: 32.60 PB Ratio: 5.34 GF Score: 89/100

AstraZeneca PLC at JPMorgan Healthcare Conference Transcript

Jan 09, 2024 / NTS GMT
Release Date Price: £109.02 (+1.21%)
James Daniel Gordon
JPMorgan Chase & Co, Research Division - Senior Analyst

Good afternoon. I'm James Gordon, JPMorgan European pharma and biotech analyst. And today, I've got the pleasure of introducing the AstraZeneca presentation. So you're going to hear from AstraZeneca CFO, Aradhana Sarin. Thank you very much for joining us today, Aradhana. Really looking forward to the presentation.

Aradhana Sarin
AstraZeneca PLC - CFO & Executive Director

Thank you, James, and JPMorgan for hosting us this year. Good afternoon, everyone. It's a pleasure to be here with all of you to share the remarkable progress that AstraZeneca has made over the course of 2023 and explain some of the factors that underpin our confidence in delivering industry-leading growth through 2030 and beyond.

On this slide, you'll see some of our forward-looking statements, which I urge you to take a moment to review when you have a chance. This is an exciting time to be at AstraZeneca. In the first 9 months of 2023, we delivered $34 billion in revenue with ex-COVID medicines up 15%

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot